☆ 4.6 Article

Synthesis of A-9758, an Inverse Agonist of Retinoic Acid-Related Orphan Receptor γt

ACS OMEGA (2022)

Related references

Note: Only part of the references are listed.

Article Chemistry, Applied

Continuous Multiphase Flow Nitration and Cryogenic Flow Formylation: Enabling Process Development and Manufacturing of Pharmaceutical Intermediates

Benoit Cardinal-David et al.

Summary: The development of scalable, safe, and environmentally friendly processes in manufacturing API and pharmaceutical intermediates has led to the widespread adoption of continuous processing technology within the pharmaceutical industry. By addressing challenges associated with high exothermicity, formation of unstable intermediates, and hazardous reactions, continuous processing offers improved temperature control and safety for reactions like aromatic nitration and regioselective aryl ring metalation. Studies on transport phenomena and reactor design have resulted in the creation of safe, scalable, high-yielding, and robust continuous stirred tank flow systems and tubular flow reactor designs for large-scale production.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2021)

Add to Collection

Review Pharmacology & Pharmacy

Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases - where are we presently?

Christian Gege

Summary: The transcription factor ROR gamma t is a promising target for treating inflammatory diseases. Clinical trials of small molecule ROR gamma t inverse agonists have faced challenges, such as lack of efficacy and safety concerns. However, new potential treatments with different chemical structures offer hope for the future.

EXPERT OPINION ON DRUG DISCOVERY (2021)

Add to Collection

Article Chemistry, Medicinal

Fueling the Pipeline via Innovations in Organic Synthesis

Eric A. Voight et al.

Summary: The paramount importance of synthetic organic chemistry in the pharmaceutical industry lies in the necessity to physically prepare designed molecules to obtain key data for the design-synthesis-data cycle, with medicinal chemists at the center. Synthesis specialists accelerate medicinal chemistry innovation by rapidly identifying and executing impactful synthetic methods, addressing the synthetic accessibility bottleneck. AbbVie’s Discovery Synthesis Groups (DSGs) like Centralized Organic Synthesis (COS) bridge the gap between discovery and process chemistry, providing tools and compounds to fuel the pipeline, showcasing key contributions in developing advanced drug candidates.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Add to Collection

Review Pharmacology & Pharmacy

(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease

Anton M. Jetten et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)

Add to Collection

Article Chemistry, Medicinal

Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists

Jerome Amaudrut et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Add to Collection

Review Chemistry, Medicinal

Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)

Nannan Sun et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2019)

Add to Collection

Article Pharmacology & Pharmacy

Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt

Stephen B. Gauld et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Axially Chiral Dibenzazepinones by a Palladium(0)-Catalyzed Atropo-enantioselective C-H Arylation

Christopher G. Newton et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Add to Collection

Article Chemistry, Medicinal

Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses

Vrajesh B. Pandya et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Review Immunology

The interleukin-23/interleukin-17 Axis Links Adaptive and innate immunity in Psoriasis

Michael P. Schoen et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Chemistry, Medicinal

RORγ antagonists and inverse agonists: a patent review

Sarah M. Bronner et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2017)

Add to Collection

Article Chemistry, Medicinal

Recent progress on nuclear receptor RORγ modulators

Patrick Cyr et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Add to Collection

Review Dermatology

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

Molly Campa et al.

DERMATOLOGY AND THERAPY (2016)

Add to Collection

Article Chemistry, Medicinal

Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)

Benjamin P. Fauber et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection

Review Endocrinology & Metabolism

Action of RORs and their ligands in (patho)physiology

Laura A. Solt et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)

Add to Collection

Review Chemistry, Multidisciplinary

Practical methodologies for the synthesis of indoles

Guy R. Humphrey et al.

CHEMICAL REVIEWS (2006)

Add to Collection

Article Chemistry, Organic

A general method for C3 reductive alkylation of indoles

A Mahadevan et al.

TETRAHEDRON LETTERS (2003)

Add to Collection

Article Chemistry, Organic

A simple two-step synthesis of indoles

A Walkington et al.

SYNTHETIC COMMUNICATIONS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.